|
US5824307A
(en)
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
|
DE69332643T2
(de)
|
1992-09-16 |
2003-11-27 |
The Scripps Research Institute, La Jolla |
Menschliche, neutralisierende, monoklonale antikörper gegen das respiratorische synzytialvirus
|
|
CA2167835A1
(en)
|
1993-07-30 |
1995-02-09 |
Richard A. Weltzin |
Monoclonal iga antibody against respiratory syncytial virus
|
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
DE69609188T2
(de)
|
1995-09-18 |
2000-12-21 |
Intracel Corp., Issaquah |
Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus
|
|
US20020141990A1
(en)
|
1996-11-01 |
2002-10-03 |
Smithkline Beecham Corporation |
Anti-RSV human monoclonal antibodies
|
|
NZ518401A
(en)
|
1999-10-29 |
2004-01-30 |
Nektar Therapeutics |
Dry powder compositions having improved dispersivity
|
|
US7229619B1
(en)
|
2000-11-28 |
2007-06-12 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
EP2289550A3
(en)
|
2000-01-27 |
2012-02-15 |
MedImmune, LLC |
Ultra high affinity neutralizing antibodies
|
|
DK1259547T3
(da)
|
2000-03-01 |
2012-10-15 |
Medimmune Inc |
Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
|
|
US6565849B2
(en)
|
2000-03-02 |
2003-05-20 |
Medimmune, Inc. |
Methods of enhancing activity of vaccines and vaccine compositions
|
|
ES2338098T3
(es)
|
2000-05-03 |
2010-05-04 |
Medimmune, Llc |
Terapia de combinacion de enfermedades respiratorias usando anticuerpos y agentes antiinflamatorios.
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US6818216B2
(en)
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
US7179900B2
(en)
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US6855493B2
(en)
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US7658921B2
(en)
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
|
US7083784B2
(en)
|
2000-12-12 |
2006-08-01 |
Medimmune, Inc. |
Molecules with extended half-lives, compositions and uses thereof
|
|
US7425618B2
(en)
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
|
US20040101920A1
(en)
|
2002-11-01 |
2004-05-27 |
Czeslaw Radziejewski |
Modification assisted profiling (MAP) methodology
|
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
|
EP1617805A4
(en)
|
2003-04-11 |
2012-07-04 |
Medimmune Llc |
METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS
|
|
US7070786B2
(en)
|
2003-06-06 |
2006-07-04 |
Centocor, Inc. |
RSV proteins, antibodies, compositions, methods and uses
|
|
US7850962B2
(en)
|
2004-04-20 |
2010-12-14 |
Genmab A/S |
Human monoclonal antibodies against CD20
|
|
EP1793850A4
(en)
|
2004-09-21 |
2010-06-30 |
Medimmune Inc |
ANTIBODIES TO THE METHOD AND METHOD FOR THE PRODUCTION OF VACCINES AGAINST THE RESPIRATORY SYNCYTIAL VIRUS
|
|
US20090030187A1
(en)
|
2005-03-14 |
2009-01-29 |
Tous Guillermo I |
Macromolecules comprising a thioether cross-link
|
|
EP2450377A1
(en)
|
2006-09-07 |
2012-05-09 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
|
|
JP2010534057A
(ja)
|
2007-03-06 |
2010-11-04 |
シムフォゲン・アクティーゼルスカブ |
呼吸器合胞体ウイルス感染症を治療するための組換え抗体
|
|
EP1997830A1
(en)
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV specific binding molecules and means for producing them
|
|
CA2695309A1
(en)
|
2007-09-07 |
2009-03-12 |
Symphogen A/S |
Methods for recombinant manufacturing of anti-rsv antibodies
|
|
WO2009042589A1
(en)
|
2007-09-24 |
2009-04-02 |
Vanderbilt University |
Monoclonal antibodies to respiratory syncytial virus and uses thereof
|
|
KR100938998B1
(ko)
|
2008-01-08 |
2010-01-28 |
(주) 에이프로젠 |
호흡기 신시티움 바이러스에 대한 항체
|
|
JP5575377B2
(ja)
|
2008-07-18 |
2014-08-20 |
シスメックス株式会社 |
抗ｒｓウイルスモノクローナル抗体を用いたｒｓウイルス検出用キット及びイムノクロマトグラフィー用試験具、並びに新規な抗ｒｓウイルスモノクローナル抗体
|
|
PT2387583T
(pt)
|
2009-01-14 |
2018-12-24 |
Ablynx Nv |
Administração pulmonar de domínios de variável única de imunoglobulina e construtos dos mesmos
|
|
PT2438087T
(pt)
|
2009-06-05 |
2017-08-04 |
Ablynx Nv |
Construções de nanobody trivalentes de vírus sincicial respiratório humano (hrsv) para a prevenção e/ou tratamento de infeções do trato respiratório
|
|
US8568726B2
(en)
|
2009-10-06 |
2013-10-29 |
Medimmune Limited |
RSV specific binding molecule
|
|
US20120315270A1
(en)
|
2009-10-21 |
2012-12-13 |
The United States Of America, As Represented By The |
Rsv immunogens, antibodies and compositions thereof
|
|
CA2900110A1
(en)
*
|
2013-02-01 |
2014-08-07 |
Medimmune, Llc |
Respiratory syncytial virus f protein epitopes
|
|
TWI659968B
(zh)
|
2013-03-14 |
2019-05-21 |
再生元醫藥公司 |
針對呼吸道融合病毒ｆ蛋白質的人類抗體及其使用方法
|
|
HK1221908A1
(zh)
|
2013-04-29 |
2017-06-16 |
Adimab, Llc |
多特异(polyspecificity)试剂，其制备方法和用途
|
|
ES2795727T3
(es)
|
2014-01-15 |
2020-11-24 |
Medimmune Llc |
Anticuerpos específicos del vrs y partes funcionales de los mismos
|
|
KR20170075778A
(ko)
*
|
2014-10-27 |
2017-07-03 |
에이전시 포 사이언스, 테크놀로지 앤드 리서치 |
항-tim-3 항체
|
|
AU2017345786B2
(en)
|
2016-10-21 |
2024-08-01 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
|
CN110035771B
(zh)
|
2016-10-21 |
2024-03-08 |
阿迪马布有限责任公司 |
抗呼吸道合胞病毒抗体及其产生和使用方法
|
|
US11479600B2
(en)
|
2016-10-21 |
2022-10-25 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|